PAM
BIVV

Panagora Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Panagora Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-117,538
Closed -$6.34M – 2454
2017
Q4 		$6.34M Sell
117,538
-35,624
-23% -$1.95M 0.02% 487
2017
Q3 		$8.74M Sell
153,162
-76
-0% -$4.45K 0.03% 434
2017
Q2 		$9.22M Buy
153,238
+99,928
+187% +$5.69M 0.04% 428
2017
Q1 		$2.9M Buy
+53,310
New +$2.63M 0.01% 744

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Panagora Asset Management's BIVV Position: Q1 2018 in Review

Panagora Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 117,538 shares — an estimated $6.34M sold.

Panagora Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $9.22M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Panagora Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Panagora Asset Management sold 117,538 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $6.34M.
  • Panagora Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Panagora Asset Management's Bioverativ Inc. Common Stock position peaked at $9.22M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Panagora Asset Management's 13F filing for Q1 2018, filed 15 May 2018.